Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Economidou, K. Antoniou, K. Samara, G. Soufla, C. Choulaki, A. Proklou, I. Politis, D. Moraitaki, N. Tzanakis, N. Siafakas (Heraklion, Greece). Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases. Eur Respir J 2008; 32: Suppl. 52, 1879

Member's Comments

No comment yet.

Related content which might interest you: Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003 Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 Simultaneous mRNA expression analysis of transforming growth factor β1 and three types of TGF-β receptors in broncho-alveolar lavage cells from patients with interstitial lung diseases – the pilot study Source: Eur Respir J 2003; 22: Suppl. 45, 223s Year: 2003 CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002 Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006 Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002 Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 Upregulation of neurokinin-1 receptor expression in bronchoalveolar lavage cells and bronchial epithelium of patients with sarcoidosis compared with normal patients Source: Eur Respir J 2002; 20: Suppl. 38, 226s Year: 2002 Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007